New Insight Wealth Advisors’s AbbVie ABBV Stock Holding History

New Insight Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$740K	Sell	3,401 -489	-13%	-$108K	0.27%	58
2025 Q4	$889K	Sell	3,890 -201	-5%	-$45.8K	0.32%	55
2025 Q3	$947K	Sell	4,091 -37	-0.9%	-$7.54K	0.36%	50
2025 Q2	$766K	Sell	4,128 -16	-0.4%	-$2.97K	0.32%	47
2025 Q1	$868K	Buy	4,144 +84	+2%	+$16.3K	0.39%	42
2024 Q4	$721K	Sell	4,060 -508	-11%	-$93.4K	0.36%	41
2024 Q3	$902K	Sell	4,568 -362	-7%	-$67.6K	0.47%	35
2024 Q2	$846K	Sell	4,930 -660	-12%	-$109K	0.5%	36
2024 Q1	$1.02M	Sell	5,590 -57	-1%	-$9.82K	0.64%	31
2023 Q4	$875K	Buy	+5,647	New	+$823K	0.59%	35

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New Insight Wealth Advisors's ABBV Position: Q1 2026 in Review

New Insight Wealth Advisors reduced its AbbVie (ABBV) stake by 13% in Q1 2026, selling an estimated $108K and leaving 3,401 shares worth $740K. The position accounts for 0.27% of the portfolio, ranked #58.

New Insight Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.02M in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

New Insight Wealth Advisors held 3,401 shares of AbbVie worth $740K as of Q1 2026.
New Insight Wealth Advisors sold 489 AbbVie shares in Q1 2026, an estimated $108K.
AbbVie made up 0.27% of New Insight Wealth Advisors's portfolio in Q1 2026, its #58 holding.
New Insight Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
New Insight Wealth Advisors's AbbVie position peaked at $1.02M in Q1 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on New Insight Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.